In press future contents
Articles accepted for publication and currently in press. In this page a list of future contents of CER.
Full Papers
CER13251
Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE study
R.-M. Flipo, F. Tubach, P. Goupille, E. Lespessailles, N. Harid, S. Sequeira, P. Bertin, B. Fautrel
R.-M. Flipo, F. Tubach, P. Goupille, E. Lespessailles, N. Harid, S. Sequeira, P. Bertin, B. Fautrel
CER13179
Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study
N. Martínez-López-De-Castro, M. Álvarez-Payero, M. Samartín-Ucha, C. Martínez-Reglero, A. Martín-Vila, M. Rodríguez-Rodríguez, G. Piñeiro-Corrales, J.F. Maceiras-Pan, R.B. Melero-González, J.M. Pego-Reigosa
N. Martínez-López-De-Castro, M. Álvarez-Payero, M. Samartín-Ucha, C. Martínez-Reglero, A. Martín-Vila, M. Rodríguez-Rodríguez, G. Piñeiro-Corrales, J.F. Maceiras-Pan, R.B. Melero-González, J.M. Pego-Reigosa
CER13288
Circulating TFH cells is correlated with disease activity in anti-MDA5 antibody positive idiopathic inflammatory myopathies
M. Zhou, M. Li, C. Guo, S. Wang, X. Li, S. Zhao, H. Zhang, N. Yang
M. Zhou, M. Li, C. Guo, S. Wang, X. Li, S. Zhao, H. Zhang, N. Yang
CER13285
Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA.hy926 endothelial cell line
C. Barbati, T. Colasanti, M. Vomero, F. Ceccarelli, A.I. Celia, C. Perricone, F.R. Spinelli, F. Conti, G. Valesini, C. Alessandri
C. Barbati, T. Colasanti, M. Vomero, F. Ceccarelli, A.I. Celia, C. Perricone, F.R. Spinelli, F. Conti, G. Valesini, C. Alessandri
CER13283
The indirect immunofluorescence assay autoantibody profiles of myositis patients without known myositis-specific autoantibodies
M. Casal-Dominguez, I. Pinal-Fernandez, K. Pak, A. Marin-Sanchez, M.T. Sanz-Martinez, A. Baucells, Y. Hosono, L. Christopher-Stine, A.L. Mammen
for the Johns Hopkins Myositis Center Group
M. Casal-Dominguez, I. Pinal-Fernandez, K. Pak, A. Marin-Sanchez, M.T. Sanz-Martinez, A. Baucells, Y. Hosono, L. Christopher-Stine, A.L. Mammen
for the Johns Hopkins Myositis Center Group
CER13275
Prevalence and outcome of thrombocytopenia in systemic lupus erythematous: single-centre cohort analysis
T. Costa Pires, R. Caparrós-Ruiz, P. Gaspar, D.A. Isenberg
T. Costa Pires, R. Caparrós-Ruiz, P. Gaspar, D.A. Isenberg
CER13270
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy
M.C. Ditto, S. Parisi, V. Varisco, R. Talotta, A. Batticciotto, M. Antivalle, M.C. Gerardi, M. Agosti, R. Borrelli, E. Fusaro, P. Sarzi-Puttini
M.C. Ditto, S. Parisi, V. Varisco, R. Talotta, A. Batticciotto, M. Antivalle, M.C. Gerardi, M. Agosti, R. Borrelli, E. Fusaro, P. Sarzi-Puttini
CER13268
Is Takayasu's arteritis more severe in children?
E.C. Bolek, U. Kaya Akca, A. Sari, E. Sag, S. Demir, L. Kilic, Y.Z. Sener, H.H. Aykan, E.B. Kaya, Y. Bilginer, A. Akdogan, S. Kiraz, O. Karadag, S. Ozen
E.C. Bolek, U. Kaya Akca, A. Sari, E. Sag, S. Demir, L. Kilic, Y.Z. Sener, H.H. Aykan, E.B. Kaya, Y. Bilginer, A. Akdogan, S. Kiraz, O. Karadag, S. Ozen
CER13261
Naturalistic 6-month antidepressants follow-up in patients with fibromyalgia: impact on somatic and mood spectrum symptoms
C. Carmassi, A. Ciapparelli, A. Cappelli, V. Dell'oste, C.A. Bertelloni, C. Foghi, G. Amatori, V. Pedrinelli, L. Bazzichi, L. Dell'osso
C. Carmassi, A. Ciapparelli, A. Cappelli, V. Dell'oste, C.A. Bertelloni, C. Foghi, G. Amatori, V. Pedrinelli, L. Bazzichi, L. Dell'osso
CER13259
Adult Autism Subthreshold spectrum correlates to Post-traumatic Stress Disorder spectrum in patients with fibromyalgia
C. Carmassi, A. Cordone, A. Ciapparelli, C.A. Bertelloni, F.M. Barberi, C. Foghi, V. Pedrinelli, V. Dell'oste, L. Bazzichi, L. Dell'osso
C. Carmassi, A. Cordone, A. Ciapparelli, C.A. Bertelloni, F.M. Barberi, C. Foghi, V. Pedrinelli, V. Dell'oste, L. Bazzichi, L. Dell'osso
CER13306
Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry
C. Lukas, M. Redondin, I. Pane, M. Soubrier, E. Houvenagel, J. Sibilia, B. Combe, J. Morel
C. Lukas, M. Redondin, I. Pane, M. Soubrier, E. Houvenagel, J. Sibilia, B. Combe, J. Morel
CER13256
The effect of methotrexate on neutrophil reactive oxygen species and CD177 expression in rheumatoid arthritis
U. Kaundal, A. Khullar, B. Leishangthem, S. Jain, A. Dhooria, B. Saikia, V. Dhir
U. Kaundal, A. Khullar, B. Leishangthem, S. Jain, A. Dhooria, B. Saikia, V. Dhir
CER13317
Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre
I. Gonzalez-Mazón, L. Sánchez-Bilbao, J.L. Martín-Varillas, A. García-Castaño, M. Delgado-Ruiz, I. Bernat Piña, J.L. Hernández, S. Castañeda, J. Llorca, M.A. González-Gay, R. Blanco
I. Gonzalez-Mazón, L. Sánchez-Bilbao, J.L. Martín-Varillas, A. García-Castaño, M. Delgado-Ruiz, I. Bernat Piña, J.L. Hernández, S. Castañeda, J. Llorca, M.A. González-Gay, R. Blanco
CER13248
Severely destructive unilateral wrist arthritis as a rare variant of rheumatoid arthritis: analysis of clinical and imaging features
V. Korendovych, J. Fleischhammer, B. Tampe, E. Nikiphorou, R. Vasko, G.A. Müller, P. Korsten
V. Korendovych, J. Fleischhammer, B. Tampe, E. Nikiphorou, R. Vasko, G.A. Müller, P. Korsten
CER13247
Subphenotypes of ANCA-associated vasculitis identified by latent class analysis
K. Wójcik, G. Biedroń, K. Wawrzycka-Adamczyk, S. Bazan-Socha, A. Ćmiel, Z. Zdrojewski, A. Masiak, Z. Czuszyńska, M. Majdan, R. Jeleniewicz, M. Klinger, M. Krajewska, M. Kusztal, M. Brzosko, B. Iwona, A. Dębska-Ślizień, H. Storoniak, B. Bułło-Piontecka, W. Tłustochowicz, J. Kur-Zalewska, M. Wisłowska, M. Madej, A. Hawrot-Kawecka, P. Głuszko, M. Stasiek, E. Kucharz, J. Musiał
K. Wójcik, G. Biedroń, K. Wawrzycka-Adamczyk, S. Bazan-Socha, A. Ćmiel, Z. Zdrojewski, A. Masiak, Z. Czuszyńska, M. Majdan, R. Jeleniewicz, M. Klinger, M. Krajewska, M. Kusztal, M. Brzosko, B. Iwona, A. Dębska-Ślizień, H. Storoniak, B. Bułło-Piontecka, W. Tłustochowicz, J. Kur-Zalewska, M. Wisłowska, M. Madej, A. Hawrot-Kawecka, P. Głuszko, M. Stasiek, E. Kucharz, J. Musiał
CER13223
Tissue factor and human apolipoprotein H genetic variants and pro-inflammatory cytokines in systemic lupus erythematosus patients
A. Wajda, A. Sowińska, E. Haładyj, B. Stypińska, J. Nałęcz-Janik, P.P. Jagodziński, D. Majewski, M. Olesińska, A. Paradowska-Gorycka
A. Wajda, A. Sowińska, E. Haładyj, B. Stypińska, J. Nałęcz-Janik, P.P. Jagodziński, D. Majewski, M. Olesińska, A. Paradowska-Gorycka
CER13695
Rituximab for refractory manifestations of the antiphospholipid syndrome: a multicentre Israeli experience
N. Agmon-Levin, M. Berman, L. Harel, M. Lidar, T. Drori, S. Hajyahia, D. Paran
N. Agmon-Levin, M. Berman, L. Harel, M. Lidar, T. Drori, S. Hajyahia, D. Paran
CER13322
Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database
E. Bilgin, S.Z. Aydin, I. Tinazzi, Ö. Bayindir, G. Kimyon, C. Özişler, A. Doğru, E. Dalkiliç, K. Aksu, G. Yildirim Çetin, S. Yilmaz, D. Solmaz, A. Omma, M. Can, O. Küçükşahin, Ş. Yavuz, E.D. Ersözlü, L. Kiliç, E.F. Tarhan, M. Aydin Tufan, L. Akyol, M. Çinar, A. Erden, E. Gönüllü, F. Yildiz, S. Bakirci, F. Erbasan, S. Ergülü Eşmen, A. Küçük, A. Tufan, A. Balkarli, R. Mercan, Ş. Erten, S. Akar, T. Kaşifoğlu, T. Duruöz, V. Yazisiz, U. Kalyoncu
E. Bilgin, S.Z. Aydin, I. Tinazzi, Ö. Bayindir, G. Kimyon, C. Özişler, A. Doğru, E. Dalkiliç, K. Aksu, G. Yildirim Çetin, S. Yilmaz, D. Solmaz, A. Omma, M. Can, O. Küçükşahin, Ş. Yavuz, E.D. Ersözlü, L. Kiliç, E.F. Tarhan, M. Aydin Tufan, L. Akyol, M. Çinar, A. Erden, E. Gönüllü, F. Yildiz, S. Bakirci, F. Erbasan, S. Ergülü Eşmen, A. Küçük, A. Tufan, A. Balkarli, R. Mercan, Ş. Erten, S. Akar, T. Kaşifoğlu, T. Duruöz, V. Yazisiz, U. Kalyoncu
CER13221
Low-dose IL-2 effectively restored decreased regulatory T cells in patients with Behçet’s disease
X. Liu, W. Li, X. Liu, J. Luo, C. Gao, X. Li
X. Liu, W. Li, X. Liu, J. Luo, C. Gao, X. Li
CER13202
Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjögren’s syndrome
X. Zhao, Y. Gan, Y. Jin, J. He, R. Jia, Y. Li, H. Luan, H. Ye, Q. Wang, Y. Liu, D. Shen, X. Sun, Z. Li
X. Zhao, Y. Gan, Y. Jin, J. He, R. Jia, Y. Li, H. Luan, H. Ye, Q. Wang, Y. Liu, D. Shen, X. Sun, Z. Li
CER13194
Atherosclerosis in rheumatoid arthritis: associations between anti-cytomegalovirus IgG antibodies, CD4+CD28null T-cells, CD8+CD28null T-cells and intima-media thickness
B. Wahlin, A.E. Fasth, K. Karp, K. Lejon, V. Malmström, A. Rahbar, S. Wållberg-Jonsson, A. Södergren
B. Wahlin, A.E. Fasth, K. Karp, K. Lejon, V. Malmström, A. Rahbar, S. Wållberg-Jonsson, A. Södergren
CER13185
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study
A. Dalbeni, A. Giollo, F. Cattazzo, M. Bevilacqua, A. Mantovani, A. Tagetti, G. Orsolini, G. Cioffi, F. Ognibeni, P. Minuz, M. Rossini, O. Viapiana, C. Fava
A. Dalbeni, A. Giollo, F. Cattazzo, M. Bevilacqua, A. Mantovani, A. Tagetti, G. Orsolini, G. Cioffi, F. Ognibeni, P. Minuz, M. Rossini, O. Viapiana, C. Fava
CER13543
Trends in hospitalisations and inpatient mortality from acute myocardial infarction among patients with psoriatic arthritis: an analysis of nationwide inpatient sample 2004-2014
S. Jatwani, K. Jatwani, P. Tiwari, N. Wadhwa, K. Chugh
S. Jatwani, K. Jatwani, P. Tiwari, N. Wadhwa, K. Chugh
CER13257
Associations between histogram analysis parameters derived from morphological sequences and histopathological tissue alterations in myositis and other myopathies: a preliminary study
H.-J. Meyer, I. Schneider, A. Emmer, M. Kornhuber, A. Surov
H.-J. Meyer, I. Schneider, A. Emmer, M. Kornhuber, A. Surov
CER13426
Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis
M.G. Lazzaroni, C. Campochiaro, E. Bertoldo, G. De Luca, C. Caimmi, A. Tincani, F. Franceschini, P. Airò
M.G. Lazzaroni, C. Campochiaro, E. Bertoldo, G. De Luca, C. Caimmi, A. Tincani, F. Franceschini, P. Airò
CER12946
Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis.
M. Bellan, M. Quaglia, A. Nerviani, D. Mauro, M. Lewis, F. Goegan, A. Gibbin, S. Pagani, L. Salmi, L. Molinari, L.M. Castello, G.C. Avanzi, V. Cantaluppi, M. Pirisi, P.P. Sainaghi, C. Pitzalis
M. Bellan, M. Quaglia, A. Nerviani, D. Mauro, M. Lewis, F. Goegan, A. Gibbin, S. Pagani, L. Salmi, L. Molinari, L.M. Castello, G.C. Avanzi, V. Cantaluppi, M. Pirisi, P.P. Sainaghi, C. Pitzalis
CER13493
Impact of a pharmacist-led programme on biologics knowledge and adherence in patients with spondyloarthritis
L. Gutermann, S. Dumas, C. Lopez-Medina, L. Boissinot, C. Cotteret, V. Perut, A. Molto, O. Conort, M. Dougados
L. Gutermann, S. Dumas, C. Lopez-Medina, L. Boissinot, C. Cotteret, V. Perut, A. Molto, O. Conort, M. Dougados
CER13487
Antibody to peptidoglycan recognition protein (PGLYRP)-2 as a novel biomarker in rheumatoid arthritis
F. Huang, X. Liu, Y. Cheng, X. Sun, Y. Li, J. Zhao, D. Cao, Q. Wu, X. Pan, H. Deng, M. Tian, Z. Li
F. Huang, X. Liu, Y. Cheng, X. Sun, Y. Li, J. Zhao, D. Cao, Q. Wu, X. Pan, H. Deng, M. Tian, Z. Li
CER13484
NKG2D ligands in inflammatory joint diseases: analysis in human samples and mouse models
A. Mariotte, L. Bernardi, C. Macquin, A. Decauwer, I. Kotova, S. Blüml, D. Noël, A. Scanu, L. Punzi, R. Carapito, J. Sibilia, S. Bahram, P. Georgel
A. Mariotte, L. Bernardi, C. Macquin, A. Decauwer, I. Kotova, S. Blüml, D. Noël, A. Scanu, L. Punzi, R. Carapito, J. Sibilia, S. Bahram, P. Georgel
CER13476
Histone deacetylase 1 is increased in rheumatoid arthritis synovium and promotes synovial cell hyperplasia and synovial inflammation in the collagen-induced arthritis mouse model via the microRNA-124-dependent MARCKS-JAK/STAT axis
Q. Meng, B. Pan, P. Sheng
Q. Meng, B. Pan, P. Sheng
CER13472
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study
S. D’angelo, N. Malavolta, C. Scambi, C. Salvarani, F. Caso, E. Tirri, R. Ramonda, L. Quarta, G.L. Erre, M. Riva, R. Buono, F. Furini, R.D. Grembiale, C. Lomater, F. Cantini, T. Maio, M.S. Chimenti, R. Scrivo, F. Salaffi, R.F. Caporali, P. Volpe, G. Gualberti, F. Marando, A. Marchesoni
S. D’angelo, N. Malavolta, C. Scambi, C. Salvarani, F. Caso, E. Tirri, R. Ramonda, L. Quarta, G.L. Erre, M. Riva, R. Buono, F. Furini, R.D. Grembiale, C. Lomater, F. Cantini, T. Maio, M.S. Chimenti, R. Scrivo, F. Salaffi, R.F. Caporali, P. Volpe, G. Gualberti, F. Marando, A. Marchesoni
CER13459
Orthostatic stress testing in myalgic encephalomyelitis/chronic fatigue syndrome patients with or without concomitant fibromyalgia: effects on pressure pain thresholds and temporal summation
C.(.M. Van Campen, P.C. Rowe, F.W. Verheugt, F.C. Visser
C.(.M. Van Campen, P.C. Rowe, F.W. Verheugt, F.C. Visser
CER13455
Insulin-like growth factor binding protein 7 as a candidate biomarker for systemic sclerosis
Y.-M. Yan, J.-N. Zheng, Y. Li, Q.-R. Yang, W.-Q. Shao, Q. Wang
Y.-M. Yan, J.-N. Zheng, Y. Li, Q.-R. Yang, W.-Q. Shao, Q. Wang
CER13473
HLA-B[*]27 is significantly enriched in Nordic patients with psoriatic arthritis mutilans
P. Nikamo, B. Gudbjornsson, L. Laasonen, L. Ejstrup, L. Iversen, U. Lindqvist, L. Padyukov, M. Ståhle
P. Nikamo, B. Gudbjornsson, L. Laasonen, L. Ejstrup, L. Iversen, U. Lindqvist, L. Padyukov, M. Ståhle
CER13297
Clusterin is upregulated in serum and muscle tissue in idiopathic inflammatory myopathies and associates with clinical disease activity and cytokine profile
T. Kropáčková, L. Vernerová, H. Štorkánová, V. Horváthová, M. Vokurková, M. Klein, S. Oreská, M. Špiritović, B. Heřmánková, K. Kubínová, L.A. Cerezo, O. Kryštůfková, H. Mann, J. Ukropec, B. Ukropcová, J. Zámečník, M. Tomčík, J. Vencovský, L. Šenolt
T. Kropáčková, L. Vernerová, H. Štorkánová, V. Horváthová, M. Vokurková, M. Klein, S. Oreská, M. Špiritović, B. Heřmánková, K. Kubínová, L.A. Cerezo, O. Kryštůfková, H. Mann, J. Ukropec, B. Ukropcová, J. Zámečník, M. Tomčík, J. Vencovský, L. Šenolt
CER13437
Pain and transition: evaluating fibromyalgia in transgender individuals
D. Levit, I. Yaish, S. Shtrozberg, V. Aloush, Y. Greenman, J.N. Ablin
D. Levit, I. Yaish, S. Shtrozberg, V. Aloush, Y. Greenman, J.N. Ablin
CER13159
Phagocytosis and inflammation in crystal-induced arthritis: a synovial fluid and in vitro study
C. Baggio, P. Sfriso, A. Cignarella, P. Galozzi, A. Scanu, F. Mastrotto, M. Favero, R. Ramonda, F. Oliviero
C. Baggio, P. Sfriso, A. Cignarella, P. Galozzi, A. Scanu, F. Mastrotto, M. Favero, R. Ramonda, F. Oliviero
CER13406
Evaluating renal outcome of ANCA-associated renal vasculitis: comparative study of two histopathological scoring systems
X.-N. An, Z.-N. Wei, X.-Y. Yao, J. Xu, W.-T. Qian, X.-X. Pan, P.-Y. Shen, H. Shi, W. Zhang, X.-N. Chen, N. Chen, Y.-X. Chen
X.-N. An, Z.-N. Wei, X.-Y. Yao, J. Xu, W.-T. Qian, X.-X. Pan, P.-Y. Shen, H. Shi, W. Zhang, X.-N. Chen, N. Chen, Y.-X. Chen
CER13391
Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjögren’s syndrome
M. Mona, S. Mondello, J.Y. Hyon, W. Saleh, K. Han, H.-J. Lee, Y.-J. Ha, E.H. Kang, Y.J. Lee, S. Cha
M. Mona, S. Mondello, J.Y. Hyon, W. Saleh, K. Han, H.-J. Lee, Y.-J. Ha, E.H. Kang, Y.J. Lee, S. Cha
CER13389
Secukinumab’s effect on structural damage progression in psoriatic arthritis: longitudinal mixture modelling of FUTURE-1 and FUTURE-5
O. Luttringer, T. Fox, L. Pricop, C. Gaillez, H. Karcher, W. Wiecek, Z. Angehrn, B. Amzal
O. Luttringer, T. Fox, L. Pricop, C. Gaillez, H. Karcher, W. Wiecek, Z. Angehrn, B. Amzal
CER13385
Efficacy of leflunomide in the treatment of vasculitis
N. Mustapha, L. Barra, S. Carette, D. Cuthbertson, N.A. Khalidi, C.L. Koening, C.A. Langford, C.A. Mcalear, N. Milman, L.W. Moreland, P.A. Monach, P. Seo, U. Specks, A.G. Sreih, S.Y. Ytterberg, P.A. Merkel, C. Pagnoux
on behalf of the Canadian Vasculitis Research Network (CanVasc) and Vasculitis Clinical Research Consortium (VCRC)
N. Mustapha, L. Barra, S. Carette, D. Cuthbertson, N.A. Khalidi, C.L. Koening, C.A. Langford, C.A. Mcalear, N. Milman, L.W. Moreland, P.A. Monach, P. Seo, U. Specks, A.G. Sreih, S.Y. Ytterberg, P.A. Merkel, C. Pagnoux
on behalf of the Canadian Vasculitis Research Network (CanVasc) and Vasculitis Clinical Research Consortium (VCRC)
CER13375
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data
G. Kimyon, U. Kalyoncu, S. Kiraz, C. Bes, N. Coşkun, B. Yağiz, O. Küçükşahin, N. Kanitez, A. Erden, L. Kiliç, E. Bilgin, T. Kaşifoğlu, H. Emmungil, S.S. Koca, S. Akar, M. Çinar, V. Yazisiz, A. Ateş, D. Ersözlü, E. Gönüllü, R. Mercan, İ. Ertenli
G. Kimyon, U. Kalyoncu, S. Kiraz, C. Bes, N. Coşkun, B. Yağiz, O. Küçükşahin, N. Kanitez, A. Erden, L. Kiliç, E. Bilgin, T. Kaşifoğlu, H. Emmungil, S.S. Koca, S. Akar, M. Çinar, V. Yazisiz, A. Ateş, D. Ersözlü, E. Gönüllü, R. Mercan, İ. Ertenli
CER13367
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
L. Riancho-Zarrabeitia, V.M. Martínez-Taboada, I. Rúa-Figueroa, F. Alonso, M. Galindo-Izquierdo, J. Ovalles, A. Olivé-Marqués, N. Mena Vázquez, J. Calvo-Alén, R. Menor Almagro, E. Tomero Muriel, E. Uriarte Isacelaya, A. Boteanu, M. Andres, M. Freire González, G. Santos Soler, M.E. Ruiz-Lucea, M. Ibáñez-Barceló, I. Castellví, C. Galisteo, V. Quevedo Vila, E. Raya, J. Narváez, L. Expósito, J.A. Hernández Beriaín, L. Horcada, E. Aurrecoechea, J.M. Pego Reigosa
L. Riancho-Zarrabeitia, V.M. Martínez-Taboada, I. Rúa-Figueroa, F. Alonso, M. Galindo-Izquierdo, J. Ovalles, A. Olivé-Marqués, N. Mena Vázquez, J. Calvo-Alén, R. Menor Almagro, E. Tomero Muriel, E. Uriarte Isacelaya, A. Boteanu, M. Andres, M. Freire González, G. Santos Soler, M.E. Ruiz-Lucea, M. Ibáñez-Barceló, I. Castellví, C. Galisteo, V. Quevedo Vila, E. Raya, J. Narváez, L. Expósito, J.A. Hernández Beriaín, L. Horcada, E. Aurrecoechea, J.M. Pego Reigosa
CER13387
Clinical efficacy of ultrasound-guided hyaluronic acid injections in patients with supraspinatus tendon tear
E. Cipolletta, R. Mashadi Mirza, A. Di Matteo, M. Di Carlo, W. Grassi, E. Filippucci
E. Cipolletta, R. Mashadi Mirza, A. Di Matteo, M. Di Carlo, W. Grassi, E. Filippucci
CER13356
18-FDG PET for large vessel vasculitis diagnosis and follow-up
F. Angelotti, R. Capecchi, A. Giorgetti, P.A. Erba, D. Genovesi, M. Emdin, A. Barison, L. Manca, V. Rocchi, P. Migliorini, A. Tavoni
F. Angelotti, R. Capecchi, A. Giorgetti, P.A. Erba, D. Genovesi, M. Emdin, A. Barison, L. Manca, V. Rocchi, P. Migliorini, A. Tavoni
CER13343
Are pain severity and current pharmacotherapies associated with quality of life, work productivity, and healthcare utilisation for people with osteoarthritis in five large European countries?
P.G. Conaghan, M.J. Doane, D.H. Jaffe, E. Dragon, L. Abraham, L. Viktrup, A.G. Bushmakin, J.C. Cappelleri, S. Perrot
P.G. Conaghan, M.J. Doane, D.H. Jaffe, E. Dragon, L. Abraham, L. Viktrup, A.G. Bushmakin, J.C. Cappelleri, S. Perrot
CER13340
Evaluation of biomarkers related to endothelial dysfunction: proof of vasculopathy in anti-melanoma differentiation-associated gene 5 dermatomyositis
C. He, J. Chen, X. Luo, B. Yan
C. He, J. Chen, X. Luo, B. Yan
CER13443
Metformin repositioning in rheumatoid arthritis
Y. Matsuoka, S. Morimoto, M. Fujishiro, K. Hayakawa, Y. Kataoka, S. Suzuki, K. Ikeda, K. Takamori, K. Yamaji, N. Tamura
Y. Matsuoka, S. Morimoto, M. Fujishiro, K. Hayakawa, Y. Kataoka, S. Suzuki, K. Ikeda, K. Takamori, K. Yamaji, N. Tamura
CER12921
Social economic costs of ankylosing spondylitis in Spain
M. Merino, O. Braçe, A. González-Domínguez, Á. Hidalgo-Vega, M. Garrido-Cumbrera, J. Gratacós
M. Merino, O. Braçe, A. González-Domínguez, Á. Hidalgo-Vega, M. Garrido-Cumbrera, J. Gratacós
CER13181
Anti-tumour necrosis factor-alpha response associated with combined CD226 and HLA-DRB1[*]0404 haplotype in rheumatoid arthritis
D.S. Gibson, C.M. Mcgeough, S. Watterson, J. Blayney, G.D. Wright, A. Pendleton, P. Gardiner, D. Small, A.J. Eakin, T. Ahmed, H.A. Murray, M.J. Latten, M.A. Crockard, J.V. Lamont, S.-D. Zhang, A.J. Bjourson
D.S. Gibson, C.M. Mcgeough, S. Watterson, J. Blayney, G.D. Wright, A. Pendleton, P. Gardiner, D. Small, A.J. Eakin, T. Ahmed, H.A. Murray, M.J. Latten, M.A. Crockard, J.V. Lamont, S.-D. Zhang, A.J. Bjourson
CER13007
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?
F. Ponchel, M.A. Van Delft, X. Xie, A.N. Burska, L. Duquenne, L.A. Trouw, P. Emery
F. Ponchel, M.A. Van Delft, X. Xie, A.N. Burska, L. Duquenne, L.A. Trouw, P. Emery
CER13003
Ultrasound assessment, unlike clinical assessment, reflects enthesitis in patients with psoriatic arthritis
Y. Yamada, K. Inui, T. Okano, K. Mandai, K. Mamoto, T. Koike, S. Takeda, E. Yamashita, Y. Yoshida, C. Tateishi, D. Tsuruta, H. Nakamura
Y. Yamada, K. Inui, T. Okano, K. Mandai, K. Mamoto, T. Koike, S. Takeda, E. Yamashita, Y. Yoshida, C. Tateishi, D. Tsuruta, H. Nakamura
CER13001
Painless and painful synovitis have similar ultrasound and clinical outcomes: one-year cohort study in longstanding rheumatoid arthritis women patients
D.F. Pereira, J. Natour, L.H. Ribeiro, F.B. Ferreira, A.R. Fernandes, R.N. Furtado
D.F. Pereira, J. Natour, L.H. Ribeiro, F.B. Ferreira, A.R. Fernandes, R.N. Furtado
CER12998
Bioinformatics analysis of gene and microRNA targets for fibromyalgia
Y. Qiu, T.-J. Zhang, L.-B. Meng, X.-T. Cheng, Z. Hua
Y. Qiu, T.-J. Zhang, L.-B. Meng, X.-T. Cheng, Z. Hua
CER12992
Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales?
F. Bandinelli, M. Benucci, F. Salaffi, M. Manetti, M. Infantino, A. Damiani, M. Manfredi, V. Grossi, A. Matucci, F. Li Gobbi, G. Marin
F. Bandinelli, M. Benucci, F. Salaffi, M. Manetti, M. Infantino, A. Damiani, M. Manfredi, V. Grossi, A. Matucci, F. Li Gobbi, G. Marin
CER12977
Association between psychological constructs and physical and emotional distress in individuals with fibromyalgia
S. Maurel, N. Calvo, N. Sáez-Francàs, J. Alegre, J. Castro-Marrero
S. Maurel, N. Calvo, N. Sáez-Francàs, J. Alegre, J. Castro-Marrero
CER12970
Bone mineral density in patients with systemic mastocytosis: correlations with clinical and histopathological features
H.-J. Meyer, W. Pönisch, A. Monecke, P. Gundermann, A. Surov
H.-J. Meyer, W. Pönisch, A. Monecke, P. Gundermann, A. Surov
CER12953
The expression characteristics of cytochrome C oxidase subunit I in mitochondrial of MRL/lpr lupus mice
S. Zhang, Y. Deng, X. Huang, N. Li, H. Fan, B. Xiang, Y. Wu, X. Cheng, X. Chen
S. Zhang, Y. Deng, X. Huang, N. Li, H. Fan, B. Xiang, Y. Wu, X. Cheng, X. Chen
CER13021
Endoplasmic reticulum stress perpetuated toll-like receptor signalling-mediated inflammation in rheumatoid arthritis via X-box-binding protein-1
F. Hu, Y. Tang, P. Wang, M. Bai, X. Li, J. Song, L. Shi, X. Sun, M. Jin, Z. Li, X. Li
F. Hu, Y. Tang, P. Wang, M. Bai, X. Li, J. Song, L. Shi, X. Sun, M. Jin, Z. Li, X. Li
CER12922
Polymyalgia rheumatica patients with and without elevated baseline acute phase reactants: distinct subgroups of polymyalgia rheumatica?
D.E. Marsman, N. Den Broeder, N. Boers, F.H. Van Den Hoogen, A.A. Den Broeder, A. Van Der Maas
D.E. Marsman, N. Den Broeder, N. Boers, F.H. Van Den Hoogen, A.A. Den Broeder, A. Van Der Maas
CER13023
Toenail abnormalities in rheumatoid arthritis patients are associated with radiographic damage and impact disability: a cross sectional study nested within a cohort
G. Sánchez-Cárdenas, I. Contreras-Yáñez, S. Méndez-Flores, J. Merayo-Chalico, A. Barrera-Vargas, J. Domínguez-Cherit, V. Pascual-Ramos
G. Sánchez-Cárdenas, I. Contreras-Yáñez, S. Méndez-Flores, J. Merayo-Chalico, A. Barrera-Vargas, J. Domínguez-Cherit, V. Pascual-Ramos
CER12908
Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study
M. Manara, R. Caporali, C. Lomater, R. Gorla, E. Fusaro, P. Sarzi-Puttini, P. Stobbione, S. Capri, L. Sinigaglia
M. Manara, R. Caporali, C. Lomater, R. Gorla, E. Fusaro, P. Sarzi-Puttini, P. Stobbione, S. Capri, L. Sinigaglia
CER12902
Assessing serum IgG4 glycosylation profiles of IgG4-related disease using lectin microarray
C. Hu, P. Zhang, L. Li, C. Liu, J. Li, W. Zhang, Y. Li
C. Hu, P. Zhang, L. Li, C. Liu, J. Li, W. Zhang, Y. Li
CER12895
Apoptosis inhibitor of macrophage/CD5L is associated with disease activity in rheumatoid arthritis
X. Wu, M. Li, T. Chen, H. Zhong, X. Lai
X. Wu, M. Li, T. Chen, H. Zhong, X. Lai
CER12867
Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls
M.K. Verheul, G.M. Janssen, A. De Ru, G. Stoeken-Rijsbergen, E.N. Levarht, J.C. Kwekkeboom, N. Bomer, A. Ioan-Facsinay, I. Meulenbelt, R.A. Cordfunke, J.W. Drijfhout, R.E. Toes, P.A. Van Veelen, L.A. Trouw
M.K. Verheul, G.M. Janssen, A. De Ru, G. Stoeken-Rijsbergen, E.N. Levarht, J.C. Kwekkeboom, N. Bomer, A. Ioan-Facsinay, I. Meulenbelt, R.A. Cordfunke, J.W. Drijfhout, R.E. Toes, P.A. Van Veelen, L.A. Trouw
CER12824
Free to view
BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis
C. Selmi, K. Krüger, A. Cantagrel, M.A. Abad Hernández, U. Freudensprung, M. Farouk Rezk, J. Addison
C. Selmi, K. Krüger, A. Cantagrel, M.A. Abad Hernández, U. Freudensprung, M. Farouk Rezk, J. Addison
CER12780
Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritis
E. Generali, M. De Santis, N. Isailovic, B. Palermo, G.M. Guidelli, A. Ceribelli, F. Alborghetti, G. Colloredo, L. Porrati, T. Matthias, A. Zucchi, C. Selmi
E. Generali, M. De Santis, N. Isailovic, B. Palermo, G.M. Guidelli, A. Ceribelli, F. Alborghetti, G. Colloredo, L. Porrati, T. Matthias, A. Zucchi, C. Selmi
CER12772
Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis
A.N. Burska, J.J. El-Jawhari, J. Wu, R.J. Wakefield, H. Marzo-Ortega, P.G. Conaghan, P. Emery, F. Ponchel, J.E. Freeston
A.N. Burska, J.J. El-Jawhari, J. Wu, R.J. Wakefield, H. Marzo-Ortega, P.G. Conaghan, P. Emery, F. Ponchel, J.E. Freeston
CER12523
Disease activity in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: the utility of the SPARCC MRI scoring system for assessment of axial spine involvement
Z. Gu, C. Li, W. Xu, Y. Xiang, C. Gao, N. Wu, Y. Zhao, Y. Cao, W. Zhang, W. Zhang
Z. Gu, C. Li, W. Xu, Y. Xiang, C. Gao, N. Wu, Y. Zhao, Y. Cao, W. Zhang, W. Zhang
CER12141
Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysis
G. Khoury, B. Combe, J. Morel, C. Lukas
G. Khoury, B. Combe, J. Morel, C. Lukas
CER12649
Free to view
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis
C. Specker, A. Alberding, M. Aringer, G.-R. Burmester, J.-P. Flacke, M.W. Hofmann, P. Kästner, H. Kellner, F. Moosig, M. Sieburg, H.-P. Tony, G. Fliedner
C. Specker, A. Alberding, M. Aringer, G.-R. Burmester, J.-P. Flacke, M.W. Hofmann, P. Kästner, H. Kellner, F. Moosig, M. Sieburg, H.-P. Tony, G. Fliedner
CER12938
The two faces of the same medal… or maybe not? Comparing osteoarthritis and calcium pyrophosphate deposition disease: a laboratory and ultrasonographic study
G. Filippou, A. Scanu, A. Adinolfi, V. Picerno, C. Toscano, A. Bortoluzzi, B. Frediani, M. Govoni, L. Punzi, C.A. Scirè
G. Filippou, A. Scanu, A. Adinolfi, V. Picerno, C. Toscano, A. Bortoluzzi, B. Frediani, M. Govoni, L. Punzi, C.A. Scirè
CER13081
Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies
J.C. Milisenda, I. Pinal-Fernandez, T.E. Lloyd, J.M. Grau, F.W. Miller, A. Selva-O'callaghan, L. Christopher-Stine, W. Stenzel, A.L. Mammen, A.M. Corse
J.C. Milisenda, I. Pinal-Fernandez, T.E. Lloyd, J.M. Grau, F.W. Miller, A. Selva-O'callaghan, L. Christopher-Stine, W. Stenzel, A.L. Mammen, A.M. Corse
CER13157
Semiquantitative analysis of sacroiliac joint to sacrum ratio of bone scintigraphy to predict spinal progression in early axial spondyloarthritis: a pilot study
H.K. Min, H.-R. Kim, Y. So, H.W. Chung, S.-H. Lee
H.K. Min, H.-R. Kim, Y. So, H.W. Chung, S.-H. Lee
CER13150
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience
F.R. Spinelli, F. Ceccarelli, C. Garufi, I. Duca, S. Mancuso, E. Cipriano, E. Dell'unto, C. Alessandri, M. Di Franco, C. Perricone, R. Priori, V. Riccieri, R. Scrivo, A. Sili Scavalli, S. Truglia, G. Valesini, F. Conti
F.R. Spinelli, F. Ceccarelli, C. Garufi, I. Duca, S. Mancuso, E. Cipriano, E. Dell'unto, C. Alessandri, M. Di Franco, C. Perricone, R. Priori, V. Riccieri, R. Scrivo, A. Sili Scavalli, S. Truglia, G. Valesini, F. Conti
CER13142
The ovarian reserve as measured by the anti-Müllerian hormone is not diminished in patients with rheumatoid arthritis compared to the healthy population
M. Lopez-Corbeto, S. Martínez-Mateu, A. Pluma, R. Ferrer, M. López-Lasanta, J.J. De Agustín, M. Barceló, A. Julià, S. Marsal
M. Lopez-Corbeto, S. Martínez-Mateu, A. Pluma, R. Ferrer, M. López-Lasanta, J.J. De Agustín, M. Barceló, A. Julià, S. Marsal
CER13128
Non-medical switching from reference to biosimilar etanercept - no evidence for nocebo effect: a retrospective analysis of real-life data
U. Kiltz, J.-C. Pudelko, S. Tsiami, X. Baraliakos, J. Braun
U. Kiltz, J.-C. Pudelko, S. Tsiami, X. Baraliakos, J. Braun
CER13127
The onset of active disease in systemic lupus erythematosus patients is characterised by excessive regulatory CD4+-T-cell differentiation
M. Schaier, C. Gottschalk, F. Kälble, L. Uhlmann, V. Eckstein, C. Müller-Tidow, S. Meuer, K. Mahnke, H.-M. Lorenz, M. Zeier, A. Steinborn
M. Schaier, C. Gottschalk, F. Kälble, L. Uhlmann, V. Eckstein, C. Müller-Tidow, S. Meuer, K. Mahnke, H.-M. Lorenz, M. Zeier, A. Steinborn
CER13126
Absolute reduction of peripheral regulatory T cell in patients with relapsing polychondritis
F.-Y. Hu, J. Wang, S.-X. Zhang, R. Su, N. Yan, C. Gao, X.-F. Li, C.-H. Wang
F.-Y. Hu, J. Wang, S.-X. Zhang, R. Su, N. Yan, C. Gao, X.-F. Li, C.-H. Wang
CER13123
The mRNA levels of TGF-β Type II receptor splice variants in monocytes are associated with disease activity in patients with rheumatoid arthritis
A. Carrea, M.A. Preisegger, J. Velasco Zamora, R.A. Dewey
A. Carrea, M.A. Preisegger, J. Velasco Zamora, R.A. Dewey
CER13125
Obesity potentially protects against systemic bone loss in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors
S.Y. Lee, K.-H. Jung, S.-G. Park, S.-R. Kwon, W. Park, M.J. Lim
S.Y. Lee, K.-H. Jung, S.-G. Park, S.-R. Kwon, W. Park, M.J. Lim
CER13103
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons
I. Convertino, E. Lucenteforte, R. Gini, V. Lorenzoni, M. Cazzato, G. Turchetti, L. Trieste, S. Ferraro, L. Leonardi, G. Roberto, N. Luciano, C. Blandizzi, M. Mosca, M. Tuccori
I. Convertino, E. Lucenteforte, R. Gini, V. Lorenzoni, M. Cazzato, G. Turchetti, L. Trieste, S. Ferraro, L. Leonardi, G. Roberto, N. Luciano, C. Blandizzi, M. Mosca, M. Tuccori
CER13018
Free to view
Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study
A. Saraux, B. Combe, F. Fagnani, G. Cukierman, I. Bru, J.-M. Joubert, J.-C. Schuller, J. Massol, R.-M. Flipo
A. Saraux, B. Combe, F. Fagnani, G. Cukierman, I. Bru, J.-M. Joubert, J.-C. Schuller, J. Massol, R.-M. Flipo
CER13083
Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy
D. Prieto-Peña, M. Calderón-Goercke, A. Adán, L. Chamorro-López, O. Maíz-Alonso, J.R. De dios-Jiménez aberásturi, R. Veroz, S. Blanco, J.M. Martín-Santos, F. Navarro, A. Gallego, S. González-Suárez, A. Conesa, A. García-Valle, M. Cordero-Coma, N. Pardiñas-Barón, R. Demetrio, V. Calvo-Río, V.M. Martínez-Taboada, S. Castañeda, J.L. Hernández, M.A. González-Gay, R. Blanco
D. Prieto-Peña, M. Calderón-Goercke, A. Adán, L. Chamorro-López, O. Maíz-Alonso, J.R. De dios-Jiménez aberásturi, R. Veroz, S. Blanco, J.M. Martín-Santos, F. Navarro, A. Gallego, S. González-Suárez, A. Conesa, A. García-Valle, M. Cordero-Coma, N. Pardiñas-Barón, R. Demetrio, V. Calvo-Río, V.M. Martínez-Taboada, S. Castañeda, J.L. Hernández, M.A. González-Gay, R. Blanco
CER13551
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study)
C.B. Chighizola, F. Crisafulli, A. Hoxha, F. Carubbi, M. Bellan, S. Monti, L. Costa, C. Baldi, M. Radin, E. Praino, L.A. Coletto, F. Pregnolato, S. Sciascia, P.P. Sainaghi, E. Bellis, V. Ramoni, L. Quartuccio, A. Alunno, M. Gerosa, L. Andreoli
on behalf of SIRyoung
C.B. Chighizola, F. Crisafulli, A. Hoxha, F. Carubbi, M. Bellan, S. Monti, L. Costa, C. Baldi, M. Radin, E. Praino, L.A. Coletto, F. Pregnolato, S. Sciascia, P.P. Sainaghi, E. Bellis, V. Ramoni, L. Quartuccio, A. Alunno, M. Gerosa, L. Andreoli
on behalf of SIRyoung
CER13072
Gadolinium-enhanced magnetic resonance imaging in shoulders contributes accurate diagnosis and predicting recurrence to patients with polymyalgia rheumatica
H. Nakamura, K. Kamada, M. Tarumi, S. Tanimura, Y. Shibata, T. Horita
H. Nakamura, K. Kamada, M. Tarumi, S. Tanimura, Y. Shibata, T. Horita
CER13063
Ideal physical activity in association with incident ankylosing spondylitis: a community-based,
prospective cohort study
J.-M. Su, L.-F. Cui, W.-H. Yang, H.-J. Shi, C. Jin, R. Shu, H.-F. Li, X.-F. Zeng, S.-L. Wu, X. Gao
J.-M. Su, L.-F. Cui, W.-H. Yang, H.-J. Shi, C. Jin, R. Shu, H.-F. Li, X.-F. Zeng, S.-L. Wu, X. Gao
CER13061
Interleukin-33 promotes proliferation and inhibits apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis
S. Wu, Y. Jiang, Y. Teng, X. Liu, L. Zhou, W. Li
S. Wu, Y. Jiang, Y. Teng, X. Liu, L. Zhou, W. Li
CER13047
Iguratimod ameliorates rheumatoid arthritis progression through regulating miR-146a mediated IRAK1 expression and TRAF6/JNK1 pathway: an in vivo and in vitro study
R. Kong, J. Gao, L. Ji, Y. Peng, J. Zhang, D. Zhao
R. Kong, J. Gao, L. Ji, Y. Peng, J. Zhang, D. Zhao
CER13046
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept
R. Kumar, S. Piantoni, M. Boldini, E. Garrafa, C. Bazzani, M. Fredi, R. Ottaviani, I. Cavazzana, A. Tincani, F. Franceschini
R. Kumar, S. Piantoni, M. Boldini, E. Garrafa, C. Bazzani, M. Fredi, R. Ottaviani, I. Cavazzana, A. Tincani, F. Franceschini
CER13042
Inhibition of transient receptor potential canonical 6 attenuates fibroblast-like synoviocytes mediated synovial inflammation and joint destruction in rheumatoid arthritis
G. Liu, D. Xu, Y. He, J. Xu, S. Huang, W. Zhang, X. Qiu, X. Wang, J. Li, J. Huang
G. Liu, D. Xu, Y. He, J. Xu, S. Huang, W. Zhang, X. Qiu, X. Wang, J. Li, J. Huang
CER13036
Rapid and sustained improvements in patient-reported signs and symptoms with ixekizumab in biologic-naive and TNF-inadequate responder patients with psoriatic arthritis
A.-M. Orbai, D.D. Gladman, H. Goto, J.A. Birt, A.M. Gellett, C.-Y. Lin, T.K. Kvien
A.-M. Orbai, D.D. Gladman, H. Goto, J.A. Birt, A.M. Gellett, C.-Y. Lin, T.K. Kvien
CER13058
Aberrant distribution of CD3+CD56+ NKT-like cells in patients with primary Sjögren’s syndrome
L. Zhao, W. Xu, Z. Chen, H. Zhang, S. Zhang, C. Lian, J. Sun, H. Chen, F. Zhang
L. Zhao, W. Xu, Z. Chen, H. Zhang, S. Zhang, C. Lian, J. Sun, H. Chen, F. Zhang
CER13031
Systematic analysis of the molecular mechanisms of methotrexate therapy for rheumatoid arthritis using text mining
Q. Wang, Z. Fan, J. Li, L. Fu, L. Yan, B. Yang
Q. Wang, Z. Fan, J. Li, L. Fu, L. Yan, B. Yang
CER13024
Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry
J.H. Koh, S.-K. Lee, J. Kim, H.-A. Kim, K. Shin, J.-K. Min
J.H. Koh, S.-K. Lee, J. Kim, H.-A. Kim, K. Shin, J.-K. Min
CER13091
Novel classification of axial spondyloarthritis to predict radiographic progression using machine learning
Y.B. Joo, I.-W. Baek, K.-S. Park, I. Tagkopoulos, K.-J. Kim
Y.B. Joo, I.-W. Baek, K.-S. Park, I. Tagkopoulos, K.-J. Kim
CER14016
Disease activity at the entheses and joints are correlated in psoriatic arthritis when explored with ultrasound
G. Ayan, I. Tinazzi, S. Bakirci, U. Gazel, D. Solmaz, U. Kalyoncu, S.Z. Aydin
G. Ayan, I. Tinazzi, S. Bakirci, U. Gazel, D. Solmaz, U. Kalyoncu, S.Z. Aydin
CER13752
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology
F. Benaglio, M. Fornaro, C. Montecucco, B. Raffeiner, M. Di Franco, C. Iannuccelli, P. Conigliaro, C. Lomater, M. Govoni, E. Silvagni, A. Zanetti, S. Parisi, G. Carrara, C.A. Scirè, F. Iannone, R. Caporali
F. Benaglio, M. Fornaro, C. Montecucco, B. Raffeiner, M. Di Franco, C. Iannuccelli, P. Conigliaro, C. Lomater, M. Govoni, E. Silvagni, A. Zanetti, S. Parisi, G. Carrara, C.A. Scirè, F. Iannone, R. Caporali
CER13758
Good pain, bad pain: illness perception and physician attitudes towards rheumatoid arthritis and fibromyalgia patients
V. Aloush, D. Niv, J.N. Ablin, I. Yaish, O. Elkayam, O. Elkana
V. Aloush, D. Niv, J.N. Ablin, I. Yaish, O. Elkayam, O. Elkana
CER13831
The effects of biological agents on vascular structural lesions in Takayasu's arteritis
F. Erbasan, İ. Uçar, B. Aslan, V. Yazisiz, M.E. Terzioğlu
F. Erbasan, İ. Uçar, B. Aslan, V. Yazisiz, M.E. Terzioğlu
CER13875
Metabolomic analysis of synovial fluids from rheumatoid arthritis patients using quasi-targeted liquid chromatography-mass spectrometry/mass spectrometry
H. Wang, K. Fang, J. Wang, X. Chang
H. Wang, K. Fang, J. Wang, X. Chang
CER13878
Prevalence and clinical association with acro-osteolysis in early systemic sclerosis
A. Sakchaikul, P. Chowchuen, C. Foocharoen, P. Thammaroj
A. Sakchaikul, P. Chowchuen, C. Foocharoen, P. Thammaroj
CER13883
Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
L.E. Lee, S.S. Ahn, J.Y. Pyo, J.J. Song, Y.-B. Park, S.-W. Lee
L.E. Lee, S.S. Ahn, J.Y. Pyo, J.J. Song, Y.-B. Park, S.-W. Lee
CER13889
Galectin-3-binding protein is a novel predictor of venous thromboembolism in systemic lupus erythematosus
A.S.R. Peretz, N.S. Rasmussen, S. Jacobsen, C. Sjöwall, C.T. Nielsen
A.S.R. Peretz, N.S. Rasmussen, S. Jacobsen, C. Sjöwall, C.T. Nielsen
CER13730
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes
K. Schreiber, M. Radin, I. Cecchi, E. Rubini, D. Roccatello, S. Jacobsen, M.J. Cuadrado, S. Sciascia
K. Schreiber, M. Radin, I. Cecchi, E. Rubini, D. Roccatello, S. Jacobsen, M.J. Cuadrado, S. Sciascia
CER13991
TNF-α inhibitors reduce inflammation-induced concentric remodelling, but not diastolic dysfunction in collagen-induced arthritis
R. Le Roux, L. Mokotedi, S. Fourie, A. Manilall, S. Gunter, A.M. Millen
R. Le Roux, L. Mokotedi, S. Fourie, A. Manilall, S. Gunter, A.M. Millen
CER13812
Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares
B.F. Mandell, T.R. Fields, N.L. Edwards, A.E. Yeo, P.E. Lipsky
B.F. Mandell, T.R. Fields, N.L. Edwards, A.E. Yeo, P.E. Lipsky
CER14028
Infection versus cardiovascular disease as leading causes of hospitalisations and associated mortality in vasculitis in the U.S.: a national study
J.A. Singh
J.A. Singh
CER14031
Postural control and disability in patients with early rheumatoid arthritis
E. De Lorenzis, F. Crudo, A.L. Fedele, A. Fiorita, D. Bruno, G. Paludetti, S. Alivernini, L. Giraldi, P.M. Picciotti, A. Zoli, G. Cadoni
E. De Lorenzis, F. Crudo, A.L. Fedele, A. Fiorita, D. Bruno, G. Paludetti, S. Alivernini, L. Giraldi, P.M. Picciotti, A. Zoli, G. Cadoni
CER14048
The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome
F. Salaffi, V. Giorgi, S. Sirotti, S. Bongiovanni, S. Farah, L. Bazzichi, D. Marotto, F. Atzeni, M. Rizzi, A. Batticciotto, G. Lombardi, M. Galli, P. Sarzi-Puttini
F. Salaffi, V. Giorgi, S. Sirotti, S. Bongiovanni, S. Farah, L. Bazzichi, D. Marotto, F. Atzeni, M. Rizzi, A. Batticciotto, G. Lombardi, M. Galli, P. Sarzi-Puttini
CER14084
Usage of drugs for cardiovascular diseases is increased in systemic lupus erythematosus (SLE) patients already before diagnosis of SLE
P. Elfving, H. Kautiainen, L.J. Virta, O. Kaipiainen-Seppänen, K. Puolakka
P. Elfving, H. Kautiainen, L.J. Virta, O. Kaipiainen-Seppänen, K. Puolakka
CER14090
Secukinumab real world drug retention compared to TNF-alpha inhibitors in psoriatic arthritis
T. Eviatar, D. Zisman, O. Gendelman, T. Reitblat, A. Balbir-Gurman, T. Mashiach, R. Almog, O. Elkayam
T. Eviatar, D. Zisman, O. Gendelman, T. Reitblat, A. Balbir-Gurman, T. Mashiach, R. Almog, O. Elkayam
CER14315
Myeloid neoplasms and autoimmune diseases: markers of association
S. Galimberti, C. Baldini, C. Baratè, M. Fornili, S. Balducci, F. Ricci, F. Ferro, E. Elefante, A. Di Paolo, L. Baglietto, V. Donati, M. Petrini
S. Galimberti, C. Baldini, C. Baratè, M. Fornili, S. Balducci, F. Ricci, F. Ferro, E. Elefante, A. Di Paolo, L. Baglietto, V. Donati, M. Petrini
CER13502
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
G.M. Guidelli, O. Viapiana, N. Luciano, M. De Santis, N. Boffini, L. Quartuccio, D. Birra, E. Conticini, M.S. Chimenti, C. Bazzani, E. Bruschi, M. Riva, L.M. Canziani, G. Bianchi, M.R. Pozzi, M. Limonta, R. Gorla, R. Perricone, B. Frediani, P. Moscato, S. De Vita, L. Dagna, M. Rossini, C. Selmi
G.M. Guidelli, O. Viapiana, N. Luciano, M. De Santis, N. Boffini, L. Quartuccio, D. Birra, E. Conticini, M.S. Chimenti, C. Bazzani, E. Bruschi, M. Riva, L.M. Canziani, G. Bianchi, M.R. Pozzi, M. Limonta, R. Gorla, R. Perricone, B. Frediani, P. Moscato, S. De Vita, L. Dagna, M. Rossini, C. Selmi
CER13891
Assessment of glucocorticoid tapering in large vessel and anti-neutrophil cytoplasmic antibody-associated vasculitides
A. Mendel, D. Ennis, S. Carette, C. Pagnoux
A. Mendel, D. Ennis, S. Carette, C. Pagnoux
CER13618
Association of influenza infection with hospitalisation-related systemic lupus erythematosus flares: a time series analysis
Y.B. Joo, Y.-H. Lim, K.-J. Kim, K.-S. Park, Y.-J. Park
Y.B. Joo, Y.-H. Lim, K.-J. Kim, K.-S. Park, Y.-J. Park
CER13559
Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis
D. Prieto Peña, I. Martínez-Rodríguez, B. Atienza-Mateo, M. Calderón-Goercke, I. Banzo, M.C. González-Vela, S. Castañeda, J. Llorca, M.Á. González-Gay, R. Blanco
D. Prieto Peña, I. Martínez-Rodríguez, B. Atienza-Mateo, M. Calderón-Goercke, I. Banzo, M.C. González-Vela, S. Castañeda, J. Llorca, M.Á. González-Gay, R. Blanco
CER13564
Autoantibody profile in eosinophilic granulomatosis and polyangiitis: predominance of anti-alpha-enolase antibodies
K. Laskari, B. Hellmich, G. Adamus, E. Csernok
K. Laskari, B. Hellmich, G. Adamus, E. Csernok
CER13567
Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS
M. Vomero, A. Finucci, C. Barbati, T. Colasanti, F. Ceccarelli, L. Novelli, L. Massaro, S. Truglia, C. Pensa, F.R. Mauro, R. Foà, G. Valesini, F. Conti, C. Alessandri
M. Vomero, A. Finucci, C. Barbati, T. Colasanti, F. Ceccarelli, L. Novelli, L. Massaro, S. Truglia, C. Pensa, F.R. Mauro, R. Foà, G. Valesini, F. Conti, C. Alessandri
CER13575
Major vault protein/lung resistance related protein: a novel biomarker for rheumatoid arthritis
D. Marinou, G. Katsifis, G. Barouta, C. Liaskos, L.I. Sakkas, A. Tsakris, J.G. Routsias
D. Marinou, G. Katsifis, G. Barouta, C. Liaskos, L.I. Sakkas, A. Tsakris, J.G. Routsias
CER13589
Uric acid as a risk factor for progression to chronic kidney disease in patients with lupus nephritis: results from the KORNET registry
D.-J. Park, S.-E. Choi, H. Xu, J.-H. Kang, J.S. Lee, Y.-D. Choi, S.-S. Lee
D.-J. Park, S.-E. Choi, H. Xu, J.-H. Kang, J.S. Lee, Y.-D. Choi, S.-S. Lee
CER13874
Increased expression of interferon regulated and antiviral response genes in CD31+/CD102+ lung microvascular endothelial cells from systemic sclerosis patients with end-stage interstitial lung disease
S. Piera-Velazquez, F.A. Mendoza, S. Addya, D. Pomante, S.A. Jimenez
S. Piera-Velazquez, F.A. Mendoza, S. Addya, D. Pomante, S.A. Jimenez
CER13616
The association between active proliferative lupus nephritis during pregnancy and small for gestational age newborns
M. Ignacchiti Lacerda, B. Costa Rodrigues, G. Ramires De Jesús, F. Cunha Dos Santos, N. Ramires De Jesús, R.A. Levy, E. Mendes Klumb
M. Ignacchiti Lacerda, B. Costa Rodrigues, G. Ramires De Jesús, F. Cunha Dos Santos, N. Ramires De Jesús, R.A. Levy, E. Mendes Klumb
CER13724
Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis
P. Reid, K. Danahey, M. Lopez Velazquez, M.J. Ratain, P.H. O'donnell
P. Reid, K. Danahey, M. Lopez Velazquez, M.J. Ratain, P.H. O'donnell
CER13624
Real-world effectiveness of tofacitinib in patients with rheumatoid arthritis: a prospective observational study
A. Shouval, M. Lidar, T. Reitblat, D. Zisman, A. Balbir-Gurman, T. Mashiach, R. Almog, O. Elkayam
A. Shouval, M. Lidar, T. Reitblat, D. Zisman, A. Balbir-Gurman, T. Mashiach, R. Almog, O. Elkayam
CER13675
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study
P. Ruscitti, P. Cipriani, V. Liakouli, D. Iacono, I. Pantano, D.P.E. Margiotta, L. Navarini, G.M. Destro Castaniti, N. Maruotti, G. Di Scala, F. Caso, S. Bongiovanni, R.D. Grembiale, F. Atzeni, R. Scarpa, F. Perosa, G. Emmi, F.P. Cantatore, G. Guggino, A. Afeltra, F. Ciccia, R. Giacomelli
P. Ruscitti, P. Cipriani, V. Liakouli, D. Iacono, I. Pantano, D.P.E. Margiotta, L. Navarini, G.M. Destro Castaniti, N. Maruotti, G. Di Scala, F. Caso, S. Bongiovanni, R.D. Grembiale, F. Atzeni, R. Scarpa, F. Perosa, G. Emmi, F.P. Cantatore, G. Guggino, A. Afeltra, F. Ciccia, R. Giacomelli
CER13641
Assessment of inflammatory activity in Takayasu’s arteritis: performance of clinical scores and common biomarkers versus 18F-FDG PET/CT
D. Jiménez, M.E. Soto, L.A. Martínez-Martínez, D. Hernández-López, C. Lerma, J.A. Barragán-Garfias, I. Pérez-Torres, E. Hernández-Lemus, V. Guarner-Lans
D. Jiménez, M.E. Soto, L.A. Martínez-Martínez, D. Hernández-López, C. Lerma, J.A. Barragán-Garfias, I. Pérez-Torres, E. Hernández-Lemus, V. Guarner-Lans
CER13661
Exercise pathophysiology differs between connective tissue diseases-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension
Y. Zhang, Q. Jin, Z. Zhao, Q. Zhao, X. Yu, L. Yan, X. Li, C. An, X. Ma, C. Xiong, Q. Luo, Z. Liu
Y. Zhang, Q. Jin, Z. Zhao, Q. Zhao, X. Yu, L. Yan, X. Li, C. An, X. Ma, C. Xiong, Q. Luo, Z. Liu
CER13668
Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation
S.T. Panopoulos, M.G. Tektonidou, V.-K. Bournia, K. Laskari, P.P. Sfikakis
S.T. Panopoulos, M.G. Tektonidou, V.-K. Bournia, K. Laskari, P.P. Sfikakis
CER13670
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis
M. Carotti, D. Benfaremo, M. Di Carlo, L. Ceccarelli, M.M. Luchetti, P. Piccinni, A. Giovagnoni, F. Salaffi
M. Carotti, D. Benfaremo, M. Di Carlo, L. Ceccarelli, M.M. Luchetti, P. Piccinni, A. Giovagnoni, F. Salaffi
CER13719
Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA
Y. Muro, T. Hashimoto, S. Izumi, M. Ogawa-Momohara, T. Takeichi, H. Yamashita, H. Yasuoka, M. Akiyama
Y. Muro, T. Hashimoto, S. Izumi, M. Ogawa-Momohara, T. Takeichi, H. Yamashita, H. Yasuoka, M. Akiyama
CER13671
Higher specificity of the new EULAR/ACR 2019 criteria for diagnosing systemic lupus erythematosus in patients with biopsy-proven cutaneous lupus
M. Stec-Polak, A. Matyja-Bednarczyk, A. Wojas-Pelc, M. Pastuszczak
M. Stec-Polak, A. Matyja-Bednarczyk, A. Wojas-Pelc, M. Pastuszczak
CER13637
Effect of caffeinated and decaffeinated coffee on serum uric acid and uric acid clearance, a randomised within-subject experimental study
P. Towiwat, A. Tangsumranjit, K. Ingkaninan, K. Jampachaisri, N. Chaichamnong, B. Buttham, W. Louthrenoo
P. Towiwat, A. Tangsumranjit, K. Ingkaninan, K. Jampachaisri, N. Chaichamnong, B. Buttham, W. Louthrenoo
CER13603
Association between mortality and cytomegalovirus reactivation during remission induction therapy in patients with rheumatic diseases
Y. Ota, Y. Kaneko, T. Takeuchi
Y. Ota, Y. Kaneko, T. Takeuchi
Brief Papers
CER14054
Flare of a mixed cryoglobulinaemic vasculitis after obinutuzumab infusion
G. Martin De Fremont, A. Chiron, R. Krzysiek, S. Hacein-Bey-Abina, X. Mariette, G. Nocturne
G. Martin De Fremont, A. Chiron, R. Krzysiek, S. Hacein-Bey-Abina, X. Mariette, G. Nocturne
CER13200
Subclinical atherosclerosis evolution during 5 years of anti-TNF-alpha treatment in psoriatic arthritis patients
A. Ortolan, R. Ramonda, M. Lorenzin, R. Pesavento, A. Spinazzè, M. Felicetti, C. Nardin, M. Rattazzi, A. Doria, M. Puato
A. Ortolan, R. Ramonda, M. Lorenzin, R. Pesavento, A. Spinazzè, M. Felicetti, C. Nardin, M. Rattazzi, A. Doria, M. Puato
Review
CER13544
Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain?
M. Martínez-Lavín
M. Martínez-Lavín
CER13499
Incidence of spondyloarthritis and its subtypes: a systematic review
Y. Alamanos, E. Pelechas, P.V. Voulgari, A.A. Drosos
Y. Alamanos, E. Pelechas, P.V. Voulgari, A.A. Drosos
CER13440
Epilepsy in systemic lupus erythematosus
E.A. Grasso, M. Cacciatore, C. Gentile, L. Breda, R. Giacomelli, A. Verrotti
E.A. Grasso, M. Cacciatore, C. Gentile, L. Breda, R. Giacomelli, A. Verrotti
CER13365
Free to view
One year in review 2020: idiopathic inflammatory myopathies
G. Zanframundo, A. Tripoli, L. Cometi, E. Marcucci, F. Furini, L. Cavagna, S. Barsotti
G. Zanframundo, A. Tripoli, L. Cometi, E. Marcucci, F. Furini, L. Cavagna, S. Barsotti
CER13383
Free to view
Gender differences on psychological factors in fibromyalgia: a systematic review on male's experience
C. Conversano, R. Ciacchini, G. Orrù, M.L. Bazzichi, A. Gemignani, M. Miniati
C. Conversano, R. Ciacchini, G. Orrù, M.L. Bazzichi, A. Gemignani, M. Miniati
CER13372
Cryoglobulins: putative effectors of adaptive immune response
U. Basile, C. Napodano, M. Marino, F. Gulli, S. Colantuono, M. Casato, K. Pocino, V. Basile, L. Todi, G.L. Rapaccini, M. Visentini
U. Basile, C. Napodano, M. Marino, F. Gulli, S. Colantuono, M. Casato, K. Pocino, V. Basile, L. Todi, G.L. Rapaccini, M. Visentini
CER13424
Imaging in polymyalgia rheumatica: which technique to use?
F.A. Figus, M. Skoczyńska, R. Mcconnell, G. Massazza, A. Iagnocco
F.A. Figus, M. Skoczyńska, R. Mcconnell, G. Massazza, A. Iagnocco
CER13308
Role of prostaglandins in rheumatoid arthritis
Y. Ma, F.-F. Hong, S.-L. Yang
Y. Ma, F.-F. Hong, S.-L. Yang
CER13305
Free to view
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis
N. Crispino, F. Ciccia
N. Crispino, F. Ciccia
CER13263
Gait characteristics in patients with ankylosing spondylitis: a systematic review
J. Soulard, J. Vaillant, C.-T. Agier, N. Vuillerme
J. Soulard, J. Vaillant, C.-T. Agier, N. Vuillerme
CER13141
Free to view
The treatment of adult-onset Still’s disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature
R. Giacomelli, J. Sota, P. Ruscitti, C. Campochiaro, S. Colafrancesco, L. Dagna, D. Iacono, F. Iannone, G. Lopalco, P. Sfriso, L. Cantarini
R. Giacomelli, J. Sota, P. Ruscitti, C. Campochiaro, S. Colafrancesco, L. Dagna, D. Iacono, F. Iannone, G. Lopalco, P. Sfriso, L. Cantarini
CER13041
Guidelines on prescribing and monitoring antimalarials in rheumatic diseases: a systematic review
G. Cramarossa, H.-Y. Liu, M.A. Turk, J.E. Pope
G. Cramarossa, H.-Y. Liu, M.A. Turk, J.E. Pope
CER13348
New developments in ultrasound in rheumatology: innovative tools and promising applications
G. Sakellariou, I. Giovannini, S. Grignaschi, A. Zabotti, A. Iagnocco
G. Sakellariou, I. Giovannini, S. Grignaschi, A. Zabotti, A. Iagnocco
Letter
CER13669
Free to view
Epidemiology and clinical characteristics of COVID-19 in rheumatic diseases at a tertiary care hospital in Wuhan, China
M. Chen, Y. Wei, Q. Zhang, Q. Wan, X. Chen
M. Chen, Y. Wei, Q. Zhang, Q. Wan, X. Chen
CER13721
Free to view
Biosimilars and retention rates in patients with ankylosing spondylitis
E. Pelechas, E. Kaltsonoudis, P.V. Voulgari, A.A. Drosos
E. Pelechas, E. Kaltsonoudis, P.V. Voulgari, A.A. Drosos
CER13782
Free to view
An unusual presentation of giant cell arteritis in a middle-aged woman
E. Zampeli, C. Anagnostopoulos, H.M. Moutsopoulos
E. Zampeli, C. Anagnostopoulos, H.M. Moutsopoulos
CER13859
Free to view
Changing the traditional p-value significance threshold to .005 does not decrease the number of statistically significant p-values in observational studies more than in randomised controlled trials
M. Oztas, Z.T. Dincer, N. Sut, H. Yazici
M. Oztas, Z.T. Dincer, N. Sut, H. Yazici
CER13925
Free to view
Polymyalgia rheumatica without elevated baseline acute phase reactants
C. Manzo, M. Milchert, M. Natale, M. Brzosko
C. Manzo, M. Milchert, M. Natale, M. Brzosko
CER13644
Free to view
A prosthetic wrist joint complicated by metallosis and polyethylene synovitis, mimicking low-grade bacterial arthritis
J.W. Jacobs, A.H. Schuurman
J.W. Jacobs, A.H. Schuurman
CER14014
Free to view
Novel treatment strategy of polymyalgia rheumatica targeting drug-free remission
T. Hosoya, T. Sugihara, N. Miyasaka, S. Yasuda
T. Hosoya, T. Sugihara, N. Miyasaka, S. Yasuda
CER13907
Free to view
Sustained remission of ankylosing spondylitis following intravesical Bacillus Calmette et Guérin immunotherapy for bladder cancer
E. Toussirot, G. Guichard, P. Saas
E. Toussirot, G. Guichard, P. Saas
CER14077
Free to view
COVID-19 pandemic highlighted the importance of telemedicine in the collagen disease of systemic sclerosis
Y. Norimatsu, A. Yoshizaki, T. Fukasawa, S. Ebata, K. Oba, S. Sato
Y. Norimatsu, A. Yoshizaki, T. Fukasawa, S. Ebata, K. Oba, S. Sato
CER14229
Free to view
Retinal detachment as first manifestation of systemic lupus erythematosus
B. Iaccheri, A. Cerquaglia, E. Bartoloni, C. Cagini, T. Fiore
B. Iaccheri, A. Cerquaglia, E. Bartoloni, C. Cagini, T. Fiore
CER13949
Free to view
Pneumocystis pneumonia in patients with giant cell arteritis treated with high dose steroids: is there an indication for prophylaxis?
B.P. Krijthe, E.G. Hogendoorn-Van zwienen, D. Van Zeben
B.P. Krijthe, E.G. Hogendoorn-Van zwienen, D. Van Zeben
CER13553
Free to view
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis
P. Triggianese, A. D'antonio, P. Conigliaro, F. Buccisano, G.L. Fonti, M.S. Chimenti, R. Perricone
P. Triggianese, A. D'antonio, P. Conigliaro, F. Buccisano, G.L. Fonti, M.S. Chimenti, R. Perricone
CER13464
Free to view
Resolution of ocular and mediastinal sarcoidosis after Janus kinase inhibitor therapy for concomitant rheumatoid arthritis
L. Sejournet, L. Kodjikian, L. Grange, P. Grumet, Y. Jamilloux, P. Seve
L. Sejournet, L. Kodjikian, L. Grange, P. Grumet, Y. Jamilloux, P. Seve
CER13400
Free to view
Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary
F. Macaluso, G. Guggino, F. Ciccia
F. Macaluso, G. Guggino, F. Ciccia
CER13370
Free to view
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary
G.L. Fonti, M.S. Chimenti, E. Greco, L. Boffa, P. Conigliaro, P. Triggianese, R. Perricone
G.L. Fonti, M.S. Chimenti, E. Greco, L. Boffa, P. Conigliaro, P. Triggianese, R. Perricone
CER13302
Free to view
Expansion of CD161 expressing CD8+ single-positive and CD4+CD8+ double-positive PR3-specific T-cells in granulomatosis with polyangiitis
S. Klapa, A. Müller, A. Koch, P. Klenerman, G. Riemekasten, P. Lamprecht
S. Klapa, A. Müller, A. Koch, P. Klenerman, G. Riemekasten, P. Lamprecht
CER13282
Free to view
Evaluation of renal resistive index in different autoimmune diseases
E. Rosato, A. Gigante, R. Cianci, F.R. Spinelli, F. Ceccarelli, F. Conti
E. Rosato, A. Gigante, R. Cianci, F.R. Spinelli, F. Ceccarelli, F. Conti
CER13269
Free to view
Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus
F. Cafarelli, L. Coladonato, G. Lopalco, F. Cacciapaglia, L. Cantarini, F. Iannone
F. Cafarelli, L. Coladonato, G. Lopalco, F. Cacciapaglia, L. Cantarini, F. Iannone
CER13034
Free to view
Reply to: High prevalence of ultrasound-defined enthesitis in patients with metabolic syndrome
A. Di Matteo, E. Filippucci, E. Cipolletta, W. Grassi
A. Di Matteo, E. Filippucci, E. Cipolletta, W. Grassi
CER12945
Free to view
High prevalence of ultrasound-defined enthesitis in patients with metabolic syndrome.
Comment on: How normal is the enthesis by ultrasound in healthy subjects? Di Matteo et al.
P. Falsetti, E. Conticini, C. Baldi, C. Acciai, B. Frediani
P. Falsetti, E. Conticini, C. Baldi, C. Acciai, B. Frediani
CER12696
Free to view
Malignancies in Chinese patients with immunoglobulin G4-related disease
Z. Yang, Z. Hu
Z. Yang, Z. Hu
CER11929
Free to view
High prevalence of small intestinal bacterial overgrowth (SIBO) in spondylarthropathy
J.-M. Laroche, N. Kapel, N. Benahmed, P. Claudepierre, X. Chevalier, L. Barbot-Trystram
J.-M. Laroche, N. Kapel, N. Benahmed, P. Claudepierre, X. Chevalier, L. Barbot-Trystram
CER13929
Free to view
Unusual ossification: psoriatic arthritis or not?
R. Ramonda, S. Vio, A. Ortolan, M. Lorenzin
R. Ramonda, S. Vio, A. Ortolan, M. Lorenzin
CER13622
Free to view
Successful treatment of refractory palmoplantar psoriasis in a psoriatic arthritis patient with the JAK inhibitor tofacitinib
L. Valor-Méndez, M. Sticherling, A. Kleyer, G. Schett
L. Valor-Méndez, M. Sticherling, A. Kleyer, G. Schett
Paediatric Rheumatology
CER13686
Genetic heterogeneity in Chinese children with systemic lupus erythematosus
G. Li, H. Liu, Y. Li, T. Zhang, W. Yao, W. Guan, Y. Shi, B. Wu, H. Xu, L. Sun
G. Li, H. Liu, Y. Li, T. Zhang, W. Yao, W. Guan, Y. Shi, B. Wu, H. Xu, L. Sun
CER13751
Validation of the EULAR/ACR 2017 idiopathic inflammatory myopathy classification criteria in juvenile dermatomyositis patients
E. Sag, S. Demir, Y. Bilginer, B. Talim, G. Haliloglu, S. Ozen
E. Sag, S. Demir, Y. Bilginer, B. Talim, G. Haliloglu, S. Ozen
CER13298
Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a German cohort
S. Horn, K. Minden, F. Speth, T. Schwarz, F. Dressler, N. Grösch, J.-P. Haas, C. Hinze, G. Horneff, A. Hospach, T. Kallinich, J. Klotsche, K. Köstner, C. Meisel, M. Niewerth, P.T. Oommen, C. Schütz, F. Weller-Heinemann, N. Unterwalder, C. Sengler
S. Horn, K. Minden, F. Speth, T. Schwarz, F. Dressler, N. Grösch, J.-P. Haas, C. Hinze, G. Horneff, A. Hospach, T. Kallinich, J. Klotsche, K. Köstner, C. Meisel, M. Niewerth, P.T. Oommen, C. Schütz, F. Weller-Heinemann, N. Unterwalder, C. Sengler
CER13449
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis
C. Bava, F. Mongelli, A. Pistorio, M. Bertamino, G. Bracciolini, S. Dalprà, S. Davì, S. Lanni, V. Muratore, S. Pederzoli, S. Rosina, B. Schiappapietra, C. Suffia, G.C. Varnier, S. Verazza, G. Giancane, A. Consolaro, A. Ravelli
C. Bava, F. Mongelli, A. Pistorio, M. Bertamino, G. Bracciolini, S. Dalprà, S. Davì, S. Lanni, V. Muratore, S. Pederzoli, S. Rosina, B. Schiappapietra, C. Suffia, G.C. Varnier, S. Verazza, G. Giancane, A. Consolaro, A. Ravelli
LER & CER: letter to Editor Rheumatology
CER13693
Free to view
Evolution from hypereosinophilic bronchiolitis to eosinophilic granulomatosis with polyangiitis following COVID-19: a case report
C. Merveilleux Du Vignaux, K. Ahmad, J. Tantot, B. Rouach, J. Traclet, V. Cottin
C. Merveilleux Du Vignaux, K. Ahmad, J. Tantot, B. Rouach, J. Traclet, V. Cottin
CER14276
Free to view
Reversible diaphragmatic dysfunction in primary hyperparathyroidism
A. Dhote, C. Comparon, G. Elourimi, P.Y. Brillet, R. Dhote
A. Dhote, C. Comparon, G. Elourimi, P.Y. Brillet, R. Dhote
CER14212
Free to view
Reply to the comment of Slouma et al.: Bilateral subacromial-subdeltoid bursitis in elderly patients: a diagnostic challenge
S. Ottaviani
S. Ottaviani
CER13997
Free to view
High C-reactive protein in afebrile systemic lupus erythematosus patients without palpable synovitis: pericardial involvement should be considered
K. Mohd Idris, D. Reffat, A. O'riordan, F. Adeeb
K. Mohd Idris, D. Reffat, A. O'riordan, F. Adeeb
CER13953
Free to view
Can SARS-CoV-2 induce reactive arthritis?
M. Di Carlo, M. Tardella, F. Salaffi
M. Di Carlo, M. Tardella, F. Salaffi
CER13911
Free to view
Could the increasing concerns regarding the post-COVID-19 symptoms cause Kawasaki disease to be under-diagnosed?
F. Haslak, F. Karagozlu, M. Yildiz, A. Adrovic, R. Dedeoglu, O. Kasapcopur
F. Haslak, F. Karagozlu, M. Yildiz, A. Adrovic, R. Dedeoglu, O. Kasapcopur
CER13111
Free to view
Anti Ku antibody is associated with haematological manifestations but not with overlap features in systemic lupus erythematosus
M.B. Adarsh, C.G. Kavadichanda, S. Shah, V.S. Negi
M.B. Adarsh, C.G. Kavadichanda, S. Shah, V.S. Negi
CER13869
Free to view
Anti-MDA5 antibody-positive juvenile dermatomyositis overlap with neuropsychiatric systemic lupus erythematosus: a case report
Y. Uejima, E. Suganuma, Y. Kawano, S. Sato
Y. Uejima, E. Suganuma, Y. Kawano, S. Sato
CER13680
Free to view
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey
S. Fasano, F. Ciccia
S. Fasano, F. Ciccia
CER13598
Free to view
Comment on: Microscopic polyangiitis: clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry. by Nguyen et al.
E. Bilgin, Ö. Karadağ
E. Bilgin, Ö. Karadağ
CER13442
Free to view
Bilateral subacromial-subdeltoid bursitis in elderly patients: a diagnostic challenge
M. Slouma, I. Gharsallah
M. Slouma, I. Gharsallah
CER13388
Free to view
Pseudoscience at the expense of rheumatic disease patients during the Coronavirus disease 2019 pandemic
N. Akkoc
N. Akkoc
CER13870
Free to view
Reply to: Comment on: “Microscopic polyangiitis: clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry’’ by Nguyen et al.
Y. Nguyen, X. Puéchal
Y. Nguyen, X. Puéchal
Rapid paper
CER14204
Anakinra desensitisation in patients with cryopyrin-associated periodic syndromes
S.B. Ali, T.-T. Le, F. Kette, P. Hissaria
S.B. Ali, T.-T. Le, F. Kette, P. Hissaria
History of Medicine
CER13354
The Greek hero Achilles and his mysterious death: transdisciplinary analysis of the gouty hypothesis
E. Armocida, F.M. Galassi, S. Melintenda, M. Martini
E. Armocida, F.M. Galassi, S. Melintenda, M. Martini